|
Volumn 15, Issue 5, 2002, Pages 389-393
|
Aldosterone synthase (CYP11B2) -344 C/T polymorphism is related to antihypertensive response: Results from the Swedish Irbesartan left ventricular hypertrophy investigation versus atenolol (SILVHIA) trial
|
Author keywords
Aldosterone synthase; CYP11B2; Genetics; Hypertension; Treatment
|
Indexed keywords
ALDOSTERONE;
ALDOSTERONE SYNTHASE;
ATENOLOL;
CYTOCHROME P450 1B1;
IRBESARTAN;
ADULT;
ALDOSTERONE BLOOD LEVEL;
ARTICLE;
BLOOD PRESSURE;
CONTROLLED STUDY;
DNA DETERMINATION;
DNA STRAND;
ESSENTIAL HYPERTENSION;
FEMALE;
GENETIC POLYMORPHISM;
GENETICS;
HEART LEFT VENTRICLE HYPERTROPHY;
HUMAN;
HYPERTENSION;
MAJOR CLINICAL STUDY;
MALE;
PRIORITY JOURNAL;
ADRENERGIC BETA-ANTAGONISTS;
ALDOSTERONE;
ALDOSTERONE SYNTHASE;
ANTIHYPERTENSIVE AGENTS;
ATENOLOL;
BASE SEQUENCE;
BIPHENYL COMPOUNDS;
BLOOD PRESSURE;
CYTOSINE;
DOUBLE-BLIND METHOD;
FEMALE;
HUMANS;
HYPERTENSION;
HYPERTROPHY, LEFT VENTRICULAR;
MALE;
MIDDLE AGED;
POLYMORPHISM, GENETIC;
RECEPTOR, ANGIOTENSIN, TYPE 1;
RECEPTORS, ANGIOTENSIN;
TETRAZOLES;
THYMINE;
TREATMENT OUTCOME;
|
EID: 0036246434
PISSN: 08957061
EISSN: None
Source Type: Journal
DOI: 10.1016/S0895-7061(02)02256-2 Document Type: Article |
Times cited : (76)
|
References (15)
|